ABITRAMP1

Across TCGA pan-cancer cohorts, ABITRAMP1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated ABITRAMP1 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher ABITRAMP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ABITRAMP1 expression acts as an unfavorable survival marker, although some lineages such as OV and LUAD show a favorable association.

ESCA, DLBC, and READ are the cancer types where ABITRAMP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	All	0.229	0.847	<.001	72	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	60	view →
READ	OS	Tertile	All	0.693	0.952	<.001	60	view →
BLCA	DFS	Tertile	IV	0.108	0.478	<.001	51	view →
KIRP	OS	Tertile	All	0.729	0.896	.007	48	view →
BRCA	OS	Tertile	IV	0.269	0.818	.004	36	view →
OV	DFS	Tertile	III,IV	0.261	0.138	.013	36	view →
MESO	DFS	Tertile	III,IV	0.082	0.414	.007	27	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →
STAD	DFS	Quartile	II,III,IV	0.282	0.562	.027	8	view →
THCA	OS	Tertile	All	0.614	0.955	.032	6	view →
LUSC	OS	Tertile	III,IV	0.362	0.688	.028	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

ABITRAMP1–ESCA (DFS)

Open the ESCA breakdown →